AnalystsDev PrasadDev Prasad's Stock Forecasts
AnalystsDev Prasad
Sectors:
Industries:
Analyst Ranking
Top 32%
#1632 out of 5209 analysts
Average Return
+101.01%
Win Rate
60%3 out of 5
Risk vs Reward
Poor
Good
Dev Prasad's 5 best and worst ratings
Dev Prasad Analyst Color
Get additional color on Dev Prasad's coverage of popular stocks
Dev Prasad's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Atyr Pharma IncATYR | 1 | Hold | $1.00 | +3.63% | Downgrades | 6 months ago |
Cue Biopharma IncCUE | 1 | Strong Buy | $4.00 | +1,224.50% | Initiates Coverage On | 6 months ago |
Opus Genetics IncIRD | 1 | Strong Buy | $5.00 | +9.41% | Initiates Coverage On | 9 months ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | a year ago |
Ibio IncIBIO | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | a year ago |
Calcimedica IncCALC | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.